Friday, July 10, 2026

Drug profile · INN

floxacillin

floxacillin (FLOPEN VIATRIS) is a bacterial penicillin-binding protein inhibitor. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — floxacillin

Quick answer

floxacillin (FLOPEN VIATRIS) is a bacterial penicillin-binding protein inhibitor. Associated with Alphapharm Pty Ltd.

Key facts

INN floxacillin
Brand FLOPEN VIATRIS
Mechanism Bacterial penicillin-binding protein inhibitor
Target Bacterial penicillin-binding protein

Mechanism of action

Bacterial penicillin-binding protein inhibitor

Primary target: Bacterial penicillin-binding protein

Approval history

Authority Status Date
TGA approved

Related & competitor drugs

  1. amoxicillin Bacterial penicillin-binding protein inhibitor
  2. ampicillin sodium Bacterial penicillin-binding protein inhibitor
  3. ampicillin/ampicillin trihydrate Bacterial penicillin-binding protein inhibitor
  4. cefaclor Bacterial penicillin-binding protein inhibitor
  5. cefadroxil/cefadroxil hemihydrate Bacterial penicillin-binding protein inhibitor
  6. cefazolin sodium Bacterial penicillin-binding protein inhibitor

Frequently asked questions

What is floxacillin?

floxacillin (FLOPEN VIATRIS) is a bacterial penicillin-binding protein inhibitor. Associated with Alphapharm Pty Ltd.

What is the brand name for floxacillin?

FLOPEN VIATRIS is a marketed brand name for floxacillin. Check FDA Drugs@FDA for the current US label holder and prescribing information.